Back

Incremental value of cardiac biomarkers and cancer-related factors beyond SCORE2 for prediction of cardiovascular events

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Managing cardiovascular disease in patients with cancer: current challenges and emerging opportunities Cardio-Oncology ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Mari Nordboe Gynnild

St. Olav University Hospital, Trondheim (Norway)

5 More presentations in this session

Presentation thumbnail
C3a–C3aR1–mediated crosstalk between cardiac fibroblasts and macrophages drives the progression of ICI-associated myocarditis
Mr H. Dong (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Cardio-oncology in german inpatient care: current practice, interdisciplinary challenges and gaps in guideline implementation
Mr S. Poley (Chemnitz, DE)
Abstract Slides Video
Presentation thumbnail
Clinical implications of late gadolinium enhancement in patients with active cancer undergoing stress CMR
Doctor A. Afana (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
Assessment of long-term impact of high-dose anthracycline chemotherapy on myocardial and local arterial stiffness in childhood cancer survivors using shear wave imaging.
Doctor L. Zanella (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Uncontrolled diabetes as an independent predictor of mayor adverse cardiovascular events in prostate cancer survivors
Doctor M. Perez Nuques (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Managing cardiovascular disease in patients with cancer: current challenges and emerging opportunities

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Adverse cardiovascular events in patients with cancer: a biomarker-enhanced clinical risk score
1 September 2024
thumbnail
Congress Presentation
Residual cardiovascular risk after ACS in oncologic patients: the prognostic role of persistently elevated NT proBNP.
30 August 2026
thumbnail
Congress Presentation
Incremental value of TAPSE added to HFA-ICOS for ESC-Defined Cancer Therapy–Related Cardiac Dysfunction
28 August 2026
thumbnail
Congress Presentation
Suboptimal cardiovascular risk management in cancer survivors: analysis of statin prescription patterns following coronary calcium scoring
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources